SDMHF Company Profile and Key Details

Q: Who are the executives of SDMHF?

Benedikt OrzelekHead of Investor RelationsMs. Petra MullerHead of Investor RelationsOlivier GuitardHead of Controlling BPSMr. Heiko ImöhlVice President of Group Financing & Investor Relations

PNK : SDMHF

Sartorius Stedim Biotech SA

$220.00

At Close 4:00 PM

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Sartorius Stedim Biotech S.A. (SDMHF) stock remained unchanged at $219.88 a share on OTC. The stock opened at $229.00, fluctuating between $219.88 to $229.00 during the session.

Stock Snapshot

219.88

Prev. Close

21.39B

Market Cap

219.88

Day Low

50.1

P/E Ratio

4.389

EPS (TTM)

0.68

Cash Flow per Share

229

Open

97.3M

Number of Shares

229

Day High

29.09%

Free Float in %

39.61

Book Value

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Sep 10, 2026	219.88	219.88	219.88	219.88	12
Aug 28, 2026	229.00	229.00	229.00	229.00	90
Aug 18, 2026	210.00	210.00	210.00	210.00	2.95K
Aug 14, 2026	208.48	208.48	208.48	208.48	11
Aug 13, 2026	206.10	206.10	201.10	201.10	1.15K
Aug 12, 2026	205.94	207.50	205.94	207.50	7.15K
Aug 06, 2026	202.00	202.00	202.00	202.00	160
Aug 03, 2026	201.00	201.00	201.00	201.00	171
Jul 24, 2026	193.00	193.00	193.00	193.00	155
Jul 23, 2026	192.00	192.00	192.00	192.00	9
Jul 21, 2026	190.90	191.50	190.90	191.50	161
Jul 13, 2026	218.55	218.55	215.50	215.50	123
Jul 10, 2026	210.80	210.80	210.80	210.80	100
Jul 08, 2026	201.00	201.00	201.00	201.00	10
Jul 06, 2026	205.60	205.60	205.60	205.60	50
Jul 02, 2026	204.96	214.36	203.34	214.36	651
Jun 30, 2026	200.02	200.02	200.02	200.02	77
Jun 29, 2026	203.90	203.90	203.90	203.90	110
Jun 25, 2026	199.64	199.64	199.64	199.64	39
Jun 24, 2026	186.78	190.88	186.78	190.88	1.37K

Contact Details

Aubagne, PAC 13781

France

https://www.sartorius.com 334 428 45600

About Company

Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; reagents; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides fluid management services; biolayer interferometry instruments; microbiology testing, sterility testing, and air monitoring instruments; pipette products; sensors and analyzers; screening instruments; biomolecule analysis tools; batch liquid chromatography systems; lab data and fleet management software; live cell imaging and analysis; surface plasmon resonance solutions; water purification systems; and weighing products. In addition, the company offers data analytics software; process automation platform and software; and transfection reagents and plasmid DNA solutions. The company has a collaboration with Bio Usawa Biotechnology, Ltd. focusing on developing and manufacturing monoclonal antibodies in Sub-Saharan Africa to tackle oncology, diabetes-induced eye diseases, infectious diseases, and autoimmune conditions. It serves manufacturers of medications, vaccines, food, and chemicals, as well as research and development laboratories. The company was incorporated in 1978 and is headquartered in Aubagne, France. Sartorius Stedim Biotech S.A. is a subsidiary of Sartorius AG.

Stock Peers

ESLOF

EssilorLuxottica Société anonyme$221.31 SARTF

-35-14.11%

Sartorius Aktiengesellschaft$213.00 SAUHF

Straumann Holding AG$133.33 HOCPY

-2.01-1.67%

HOYA Corporation$118.59 HOCPF

HOYA Corporation$112.56 ESLOY

-1.7-1.51%

EssilorLuxottica Société anonyme$110.92 CZMWF

4.86+4.88%

Carl Zeiss Meditec AG$104.41 GRRMF

Gerresheimer AG$102.50 CZMWY

-2.35-2.54%

Carl Zeiss Meditec AG$90.27 ANSLY

0.32+0.51%

Ansell Limited$63.17

Company Overview

The stock is currently mid-range between its 52-week high and low $178.30 and $264.30. With a market capitalization of about $21.39 billion, Sartorius Stedim Biotech S.A. is classified as a large-cap and shows market-like volatility (beta ~1.15). Key stats such as the average daily volume over the past year has been around 314.00 shares, volume is running light vs its 52-week average. Headquartered in Aubagne, PAC, Sartorius Stedim Biotech S.A. operates in the Healthcare sector and the Medical - Instruments & Supplies industry. Led by CEO Rene Faber, the company employs approximately 10,265 people and listed since August 03, 2009. Sartorius Stedim Biotech S.A.

Technical Performance

Average 10-day trading volume of 12.00 shares is below the 3-month average of 849.62, indicating normal recent market interest.

Valuation Metrics

Sartorius Stedim Biotech S.A. trades at a P/E ratio of 62.98, slightly above the S&P 500 average, with a price-to-sales ratio of 6.13 and a price-to-book ratio of 4.36 trading at moderately above to book value. The P/FCF stands at 83.64, also above market averages.

Dividend & Fair Value

Sartorius Stedim Biotech S.A. last paid a dividend of 0.8 per share, this equals a trailing yield of roughly 0.36%. Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $21.79. This means the shares are trading above this model’s fair value.

Earnings & Analyst Outlook

Sartorius Stedim Biotech S.A. earnings surprise history is frequent misses against expectations. The quarter that ended July 23, 2026, missed forecasts by -0.69%. The prior quarter beat by -3.57%. Over the last six quarters, Apple has recorded several small beats. These include -5.39% in April 16, 2025.

Financial & Profitability Overview

Over the trailing twelve months, Sartorius Stedim Biotech SA generated $2.78B in revenue, or $30.12 per share. Gross margin was 44.44%, operating margin 17.46%, and net profit margin 11.16%. Returns are modest, with ROA at 4.00% and ROE at 11.74%.
On valuation metrics, Sartorius Stedim Biotech SA trades at a P/E of 62.98, P/S of 6.13 and P/B of 4.36. The current ratio is 1.16 and quick ratio is 0.55. Operationally, the company’s inventory turnover is 2.32 and cash conversion cycle is 133.29 days. Debt-to-equity is 0.57, supported by a cash flow-to-debt ratio of 0.26.

Quarterly Financial Highlights

For the quarter ended Dec 31, 2023, Sartorius Stedim Biotech SA posted revenue of $2.78B, down slightly from $3.49B in the prior quarter. Gross profit was $1.23B (margin 44.44%). Operating income was $484.50M (margin 17.5%). Net income was$309.70M (EPS $3.36).
The company ended the quarter with $116.60M in cash and short-term investments, a total debt of $3.68B, and net debt of $3.57B. Total assets were $7.75B, with equity of $2.67B. Financials further reflected stability, with operating cash flow of $629.70M, free cash flow of $156.10M, and capital expenditures of - $473.60M.

Price Forecast & Outlook

Our AI price prediction model suggests that Sartorius Stedim Biotech S.A. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term.

Key Takeaways

Valuation shows Sartorius Stedim Biotech S.A. trading at a premium to the broader market with a P/E of 62.98.

Frequently Asked Questions

What is the current Sartorius Stedim Biotech S.A. (SDMHF) stock price?

Sartorius Stedim Biotech S.A. (OTC: SDMHF) stock price is $219.88 in the last trading session. During the trading session, SDMHF stock reached the peak price of $229.00 while $219.88 was the lowest point it dropped to. The percentage change in SDMHF stock occurred in the recent session was 0% while the dollar amount for the price change in SDMHF stock was $0.00.

SDMHF's industry and sector of operation?

The OTC listed SDMHF is part of Medical - Instruments & Supplies industry that operates in the broader Healthcare sector. Sartorius Stedim Biotech S.A. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of SDMHF?

Benedikt Orzelek
Head of Investor Relations
Ms. Petra Muller
Head of Investor Relations
Olivier Guitard
Head of Controlling BPS
Mr. Heiko Imöhl
Vice President of Group Financing & Investor Relations

How SDMHF did perform over past 52-week?

SDMHF's closing price is 25.63% higher than its 52-week low of $178.30 where as its distance from 52-week high of $264.30 is -31.49%.

How many employees does SDMHF have?

Number of SDMHF employees currently stands at 10,265.

Link for SDMHF official website?

Official Website of SDMHF is: https://www.sartorius.com

How do I contact SDMHF?

SDMHF could be contacted at phone 334 428 45600 and can also be accessed through its website. SDMHF operates from Zone Industrielle Les Paluds, Aubagne, PAC 13781, France.

How many shares of SDMHF are traded daily?

SDMHF stock volume for the day was 40 shares. The average number of SDMHF shares traded daily for last 3 months was 314.

What is the market cap of SDMHF currently?

The market value of SDMHF currently stands at $21.39B with its latest stock price at $219.88 and 97.3M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	10265
Beta	1.15
Sales or Revenue	$2.78B
5Y Sales Change%	1.29%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Medical - Instruments & Supplies

SDMHF Company Profile and Key Details

Sartorius Stedim Biotech SA

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Company Overview

Earnings & Analyst Outlook

Dividend & Fair Value

Technical Performance

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Valuation Metrics